Role of exosomes in the metastasis of pancreatic cancer

Li Rui; Zhang HaiRong; Zhang JingLi; Zhang YuYan; Li RuoChang

doi:10.3969/j.issn.1001-5256.2020.09.055

Volume 36 Issue 9

Sep. 2020

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2020 > 36(9): 2149-2152

PDF( 228 KB)

Role of exosomes in the metastasis of pancreatic cancer

DOI: 10.3969/j.issn.1001-5256.2020.09.055

Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University

Published Date: 2020-09-20

Abstract

Abstract

Although great achievements have been made in the diagnosis and treatment of pancreatic cancer in the past several decades,the5-year survival rate of this disease is still below 10% due to high degree of malignancy,rapid progression,and strong invasion and metastasis. Exosomes are a class of nanoscale membranous vesicles that can be secreted by a variety of cells,and they carry various substances including proteins,lipids,and nucleic acids and participate in various physiological and pathological processes,such as intercellular material transport,information transmission,and development,progression,and metastasis of tumor. Studies have shown that exosomes play an important role in the metastasis of pancreatic cancer and can regulate the metastasis of pancreatic cancer by promoting epithelial-mesenchymal transition and angiogenesis to act on tumor microenvironment,affecting the formation of premetastatic microenvironment,and participating in the formation of immunosuppression microenvironment. This article reviews the research advances in exosomes in the metastasis of pancreatic cancer.
- pancreatic neoplasms,
- exosomes,
- neoplasm metastasis

FullText(HTML)

References(38)

References

[1] LUCHINI C,CAPELLI P,SCARPA A. Pancreatic ductal adenocarcinoma and its variants[J]. Surg Pathol Clin,2016,9(4):547-560.

[2] Pancreatic Cancer Committee of Chinese Anti-Cancer Association. Comprehensive guidelines for the diagnosis and treatment of pancreatic cancer(2018 version)[J]. J Clin Hepatol,2018,34(10):2109-2120.(in Chinese)中国抗癌协会胰腺癌专业委员会．胰腺癌综合诊治指南(2018版)[J]．临床肝胆病杂志，2018,34(10):2109-2120.

[3] KAMISAWA T,WOOD LD,ITOI T,et al. Pancreatic cancer[J]. The Lancet,2016,388(10039):73-85.

[4] SIEGEL RL,MILLER KD,JEMAL A. Cancer statistics,2019[J]. CA Cancer J Clin,2019,69(1):7-34.

[5] KALLURI R,LEBLEU VS. The biology,function,and biomedical applications of exosomes[J]. Science, 2020, 367(6478):eaau6977.

[6] XIE F,ZHOU X,FANG M,et al. Extracellular vesicles in cancer immune microenvironment and cancer immunotherapy[J].Adv Sci,2019,6(24):1901779.

[7] TSCHUSCHKE M,KOCHEROVA I,BRYJA A,et al. Inclusion biogenesis,methods of isolation and clinical application of human cellular exosomes[J]. J Clin Med,2020,9(2):436.

[8] PAN BT,JOHNSTONE RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro:Selective externalization of the receptor[J]. Cell,1983,33(3):967-978.

[9] BATISTA IA,MELO SA. Exosomes and the future of immunotherapy in pancreatic cancer[J]. Int J Mol Sci,2019,20(3):567.

[10] van NIEL G,D'ANGELO G,RAPOSO G. Shedding light on the cell biology of extracellular vesicles[J]. Nat Rev Mol Cell Biol,2018,19(4):213-228.

[11] LI K,CHEN Y,LI A,et al. Exosomes play roles in sequential processes of tumor metastasis[J]. Int J Cancer,2019,144(7):1486-1495.

[12] CAMPBELL K,ROSSI F,ADAMS J,et al. Collective cell migration and metastases induced by an epithelial-to-mesenchymal transition in Drosophila intestinal tumors[J]. Nat Commun,2019,10(1):2311.

[13] DIEPENBRUCK M,CHRISTOFORI G. Epithelial-mesenchymal transition(EMT)and metastasis:Yes,no,maybe?[J].Curr Opin Cell Biol,2016,43:7-13.

[14] MAIER HJ,WIRTH T,BEUG H. Epithelial-mesenchymal transition in pancreatic carcinoma[J]. Cancers(Basel),2010,2(4):2058-2083.

[15] AIELLO NM,BAJOR DL,NORGARD RJ,et al. Metastatic progression is associated with dynamic changes in the local microenvironment[J]. Nat Commun,2016,7:12819.

[16] LI Z,JIANG P,LI J,et al. Tumor-derived exosomal lncSox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma[J]. Oncogene,2018,37(28):3822-3838.

[17] TANG P,TAO L,YUAN C,et al. Serum derived exosomes from pancreatic cancer patients promoted metastasis:An i TRAQ-based proteomic analysis[J]. Onco Targets Ther,2019,12:9329-9339.

[18] WANG X,LUO G,ZHANG K,et al. Correction:Hypoxic tumorderived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγto promote pancreatic cancer metastasis[J]. Cancer Res,2020,80(4):922.

[19] VONG S,KALLURI R. The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis[J]. Genes Cancer,2011,2(12):1139-1145.

[20] BRINTON LT,SLOANE HS,KESTER M,et al. Formation and role of exosomes in cancer[J]. Cell Mol Life Sci,2015,72(4):659-671.

[21] CAI H,LIU X,ZHENG J,et al. Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma[J].Oncogene,2017,36(3):318-331.

[22] NOLAN DJ,GINSBERG M,ISRAELY E,et al. Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration[J]. Dev Cell,2013,26(2):204-219.

[23] SHANG D,XIE C,HU J,et al. Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2[J]. J Cell Mol Med,2020,24(1):588-604.

[24] CHIBA M,KUBOTA S,SATO K,et al. Exosomes released from pancreatic cancer cells enhance angiogenic activities via dynamin-dependent endocytosis in endothelial cells in vitro[J]. Sci Rep,2018,8(1):11972.

[25] LINTON SS,ABRAHAM T,LIAO J,et al. Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages[J]. PLo S One, 2018, 13(11):e0206759.

[26] NAZARENKO I,RANA S,BAUMANN A,et al. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation[J]. Cancer Res,2010,70(4):1668-1678.

[27] BLOMME A,FAHMY K,PEULEN O,et al. Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes[J]. Oncotarget,2016,7(50):83669-83683.

[28] LI J,LI Z,JIANG P,et al. Circular RNA IARS(circ-IARS)secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis[J]. J Exp Clin Cancer Res,2018,37(1):177.

[29] COSTA-SILVA B,AIELLO NM,OCEAN AJ,et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver[J]. Nat Cell Biol,2015,17(6):816-826.

[30] HOSHINO A,COSTA-SILVA B,SHEN TL,et al. Tumour exosome integrins determine organotropic metastasis[J]. Nature,2015,527(7578):329-335.

[31] RANA S,MALINOWSKA K,ZLLER M. Exosomal tumor microRNA modulates premetastatic organ cells[J]. Neoplasia,2013,15(3):281-295.

[32] WANG C,NING K,HU HH,et al. Research progress in tumor microenvironment of pancreatic cancer[J]. Chin J Dig Surg,2020,19(1):109-112.(in Chinese)王超，宁克，胡欢欢，等．胰腺癌肿瘤微环境的研究进展[J]．中华消化外科杂志，2020,19(1):109-112.

[33] BASSO D,GNATTA E,PADOAN A,et al. PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis[J].Oncotarget,2017,8(49):84928-84944.

[34] CHALMIN F,LADOIRE S,MIGNOT G,et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells[J]. J Clin Invest,2010,120(2):457-471.

[35] ZHOU M,CHEN J,ZHOU L,et al. Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203[J]. Cell Immunol,2014,292(1-2):65-69.

[36] DING G,ZHOU L,QIAN Y,et al. Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p[J]. Oncotarget,2015,6(30):29877-29888.

[37] ZECH D,RANA S,BCHLER MW,et al. Tumor-exosomes and leukocyte activation:An ambivalent crosstalk[J]. Cell Commun Signal,2012,10(1):37.

[38] QUE RS,LIN C,DING GP,et al. Increasing the immune activity of exosomes:The effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer[J]. J Zhejiang Univ Sci B,2016,17(5):352-360.

Relative Articles

[1]	Yuan ShengXian, Zhou WeiPing. Conversion therapy for hepatocellular carcinoma: Strategies and methods[J]. Journal of Clinical Hepatology, 2020, 36(2): 252-257. doi: 10.3969/j.issn.1001-5256.2020.02.002
[2]	Zhu ZeMin, Zhao ZhiJian, Tang CaiXi. Research advances in apatinib combined with transcatheter arterial embolization in the treatment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(10): 2325-2328. doi: 10.3969/j.issn.1001-5256.2020.10.036
[3]	Yang Jun, Yin Yu, Ni CaiFang, Zhu XiaoLi, Li Zhi, Zhang Shen, Huang Peng, Wang WanSheng. Value of ABCR scoring system in assessing the prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolization[J]. Journal of Clinical Hepatology, 2020, 36(9): 1980-1984. doi: 10.3969/j.issn.1001-5256.2020.09.014
[4]	Wang ZheXuan, Wang EnXin, Xia DongDong, Bai Wei, Wang QiuHe, Yuan Jie, Li XiaoMei, Niu Jing, Guo WenGang, Li Kai, Yin ZhanXin, Han GuoHong. Value of Child-Pugh score versus albumin-bilirubin grade in predicting the prognosis of unresectable hepatocellular carcinoma treated by transarterial chemoembolization[J]. Journal of Clinical Hepatology, 2020, 36(1): 113-117. doi: 10.3969/j.issn.1001-5256.2020.01.025
[5]	Tang HaoHuan, Zhu XiaoLi, Wang WanSheng, Li WanCi, Zhou LinFeng, Du Hang. Clinical effect of transarterial chemoembolization with ultra-liquid iodized oil combined with drug-eluting beads in treatment of Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(7): 1509-1513. doi: 10.3969/j.issn.1001-5256.2019.07.018
[6]	Wang YuZhe, Yin HuaBin. Feasibility of i Flow color-coding technique in quantitative real-time measurement of hemodynamic changes after transarterial chemoembolization for hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(1): 133-136. doi: 10.3969/j.issn.1001-5256.2018.01.027
[7]	Liang HongYuan, Guo QiYong, Mao XiaoNan, Sun Wei, Zhao Gang, Wang XiHai, Liu Zhen, Wen Feng, Lu ZaiMing. Clinical effect of sequential therapy with transarterial chemoembolization and bipolar-needle radiofrequency ablation in treatment of hepatocellular carcinoma in high-risk locations[J]. Journal of Clinical Hepatology, 2018, 34(7): 1462-1469. doi: 10.3969/j.issn.1001-5256.2018.07.020
[8]	Liu BoZhi, Yuan ZhuHui, Li Wei. A case of large hepatocellular carcinoma treated by transcatheter arterial chemoembolization combined with radiofrequency ablation[J]. Journal of Clinical Hepatology, 2018, 34(7): 1520-1522. doi: 10.3969/j.issn.1001-5256.2018.07.031
[9]	Wu Lei, Wang Su. Research advances in transarterial chemoembolization combined with sorafenib in treatment of advanced hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(4): 867-871. doi: 10.3969/j.issn.1001-5256.2018.04.037
[10]	Xia DongDong, Wang EnXin, Wang WenJun, Bai Wei, Yuan Jie, Han GuoHong. Early alpha-fetoprotein response can predict the prognosis of patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization[J]. Journal of Clinical Hepatology, 2017, 33(6): 1120-1125. doi: 10.3969/j.issn.1001-5256.2017.06.021
[11]	Li Xin. Short-and long-term efficacy of transarterial chemoembolization versus liver resection in treatment of patients with Barcelona stage B multiple hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(7): 1296-1300. doi: 10.3969/j.issn.1001-5256.2017.07.018
[12]	Dong DeShuo, Liu ZhaoYu. Research advances in Huai'er granules combined with transarterial chemoembolization in treatment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(10): 2021-2024. doi: 10.3969/j.issn.1001-5256.2017.09.10.037
[13]	Zhou YiLong, Chen Yuan, Zhang YiXin, Shao BingFeng, Zhang SuQing, Xu AiBing, He Song, Li YongJun, Tian SiYuan. Influence of Forkhead box Q1 expression on therapeutic effect of transarterial chemoembolization after hepatocellular carcinoma surgery[J]. Journal of Clinical Hepatology, 2016, 32(11): 2126-2129. doi: 10.3969/j.issn.1001-5256.2016.11.024
[14]	Wang WenJun, Zhao Yan, Xia DongDong, Wang EnXin, Liu Lei, Han GuoHong. Predictive value of neutrophil-lymphocyte ratio and its dynamic change in patients with hepatocellular carcinoma undergoing transarterial chemoembolization[J]. Journal of Clinical Hepatology, 2016, 32(6): 1139-1144. doi: 10.3969/j.issn.1001-5256.2016.06.024
[15]	Ma ShiJie, Zou ShaoJing, Luo XiaoLing, Li QianJun, Huang JiaSheng. Prognostic factors for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2016, 32(1): 80-83. doi: 10.3969/j.issn.1001-5256.2016.01.013
[16]	Ma JingFan, Chen Gang, Liu Hong. TACE combined with sorafenib in treatment of advanced primary hepatocellular carcinoma: a report of one case achieving complete response[J]. Journal of Clinical Hepatology, 2016, 32(1): 152-154. doi: 10.3969/j.issn.1001-5256.2016.01.030
[17]	Luo YongHeng, Xiao EnHua. Role of functional magnetic resonance imaging in evaluating the therapeutic effect of transcatheter arterial chemoembolization in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2016, 32(12): 2277-2281. doi: 10.3969/j.issn.1001-5256.2016.12.010
[18]	Gao Sheng, Liu JianYong, Zhang ZhiMing, Zhao YinNong, Yuan WeiPing, Wu FeiXiang, Xiang BangDe. Efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma before hepatectomy:a meta-analysis[J]. Journal of Clinical Hepatology, 2014, 30(9): 917-920. doi: 10.3969/j.issn.1001-5256.2014.09.020
[19]	Zhang Cheng, Chen ChangNan, Lin YunXiao, Su MingJun, Pan QiZuo, Chen ChanJuan, Rong TingJie, Xie Feng. Clinical effect of transcatheter arterial chemoembolization combined with tegafur, gimeracil, and oteracil potassium in treatment of advanced hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(1): 55-57. doi: 10.3969/j.issn.1001-5256.2014.01.012
[20]	Xin GuiJie, Zhuang ShuWu, Cai YanJun, Zhang DaWei, Chi XiuMei, Niu JunQi. Clinical study of antiviral treatment combined with transcatheter arterial chemoemholization (TACE) in patients with hepatitis B cirrhosis complicated hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2012, 28(4): 267-269.

Supplements(0)

Cited By

Cited by

Periodical cited type(3)

1.	李炎，孙永岑. 专科护士主导的O2O多学科管理在肝硬化代偿期患者中的应用. 临床护理杂志. 2024(05): 39-43 .
2.	郝志明，窦琴，包晓云. 基于PI3K/Akt信号通路探讨肝康片对四氯化碳致肝纤维化大鼠肝功能的保护机制. 现代消化及介入诊疗. 2020(02): 188-192 .
3.	朱豫萌，朱丹燕，张国强. 中西药合用治疗慢性乙型病毒性肝炎疗效观察. 实用中医药杂志. 2019(09): 1101-1103 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (1146) PDF downloads(100)

Role of exosomes in the metastasis of pancreatic cancer

DOI: 10.3969/j.issn.1001-5256.2020.09.055